收简历邮箱 ta_northchina@pfizer.com

JOB SUMMARY
The Regulatory Policy Lead is responsible for collecting, disseminating, archiving and analyzing a wide range of regulatory intelligence important to the Pfizer regulatory business.

This role facilitates the creation of Pfizer’s position on critical regulatory policy issues and promotes alignment within Pfizer. The RPL also assumes the responsibility for creating targeted advocacy plans and directly advocate through trade and professional associations and with relevant regulators.

The roles also be responsible for the training of the entire WRS China team

The RPL will work closely with regulatory policy officers, overseeing their work and providing training and mentor role.

KEY RESULT AREAS & JOB ACTIVITIES /TASKS
Develop close internal working relationships with China regulatory project team, WRS-EM, Regional Medical, Legal, P&P, and other primary stakeholders to prioritize regulatory advocating activities, and maximize business value.
Link closely with regulatory project team and other stakeholders to identify and disseminate regulatory intelligence and policy information to China leadership team, WRS Leadership, China Strategy, Med/Clinical Development, and other primary stakeholders
Analyze significant regulatory policy issues and trends that effect Pfizer China regulatory business with immediate timeframe
Facilitate the creation and dissemination of Pfizer’s regulatory policy position on critical topics, as needed.
Build and maintain relationships with China health authority policy decision-makers in order to support Pfizer’s reputation as a collaborative partner and thought leader, and to positively impact regulatory policy advocacy.
Actively involve and lead the regulatory advocacy activities initiated by RDPAC and other industry association
Manage the RP officers ensure tasks and projects are completed effectively and efficiently
Play key roles in the domestic and international industry association for regulatory advocacy activities
Make presentation in industry or regulatory conference on behalf of Pfizer

EDUCATION & EXPERIENCE REQUIREMENTS
1, Educational /Training
BA/BS, Master degree with 5+ yrs of relevant experience, in one or more of the following; regulatory policy, regulatory affairs, management, government relations, and/or related fields.
2, Working Experiences
Minimum 8 years experience in government affairs or regulatory affairs or industry association or consult company working at a high level of competency.
Strong understanding of the China regulatory environment.
Deep knowledge of pharmaceutical research, development and commercialization.

Good at Presentation in English
Good working knowledge and experience for different therapeutic areas
Good working knowledge of international and local regulatory guidelines and codes
Proficiency in Basic Microsoft Word, PowerPoint and Excel and familiarity with use of databases

COMPETENCIES REQUIREMENTS
1. Ability Functional
Ability to advocate effectively in writing and in person
Effective influencing
Communication and interpersonal skill
Judgment/problem Assessment and problem solving skill
Teamwork and Collaboration
Negotiation skill
Project management
Quality Orientation
Technical and professional knowledge

2. Cultural Competencies (Leader Behaviors)
Sustain Focus on Performance
Create an Inclusive Environment
Encourage Open Discussion and Debate
Manage Change
Develop People
lAlign Across Pfizer

自20世纪80年代进入中国以来，辉瑞始终承诺并致力于参与促进中国经济繁荣发展和提高人民健康水平。辉瑞通过不断引进创新药物、开展面向医务工作者专业培训和社会健康意识普及教育等活动，积极参与支持各项社会公益事业，全力支持中国卫生健康事业的深入发展。
1989年，辉瑞在大连建立现代化的工厂。 为实现在中国的长期发展, 辉瑞于1997年在北京成立了管理中心。2004年，辉瑞在上海成立了中国区总部和辉瑞投资有限公司。基于中国所拥有的才华横溢的科研人员群体，辉瑞中国研发中心于2005 年在上海成立。2007年，辉瑞全球财务共享服务中心（GFSS）在大连设立了亚太财务中心，该中心是GFSS位于全球的三个运营中心之一，负责处理辉瑞亚太区市场的会计业务。
目前，辉瑞中国共有近4,000名员工，在大连、苏州和无锡拥有4个现代化制药厂，业务范围涵盖全国100多个主要城市。辉瑞也是在华投资的跨国制药企业之一,累计投资额已超过5亿美元。